Skip to main content
No. of Recommendations: 0
IONS keeps giving the value away so that they can remain and R&D shop, and most of their drugs have some sort of catches that make them difficult to market. All it takes is one or two, but of those one or two it is likely IONS will give away all the value and take their 10% royalties on profits (which is even a worse deal than 10% of revenues).

When ISIS starts wanting to take some risks, focus on a few drugs with real value, and want to take them to market themselves, with no worse than a 50/50 partner, then ISIS could get out of their rut.

Tinker
Print the post  

Announcements

What was Your Dumbest Investment?
Share it with us -- and learn from others' stories of flubs.
When Life Gives You Lemons
We all have had hardships and made poor decisions. The important thing is how we respond and grow. Read the story of a Fool who started from nothing, and looks to gain everything.
Contact Us
Contact Customer Service and other Fool departments here.
Work for Fools?
Winner of the Washingtonian great places to work, and Glassdoor #1 Company to Work For 2015! Have access to all of TMF's online and email products for FREE, and be paid for your contributions to TMF! Click the link and start your Fool career.